PoS 2
ePoster 07

Programm

• • ePoster
  • P263

  Risk and reward seeking in cluster headache

  • Willemijn Naber (Leiden, NL)
• • ePoster
  • P264

  Validation of the english Cluster Headache Impact Questionnaire (CHIQ)

  • Katharina Kamm (Munich, DE)
• • ePoster
  • P265

  The enigmatic triangle of cluster headache attacks, sleep and the biological clock: rationale and protocol of the CIESTA study

  • Paulien J. van Tilborg (Leiden, NL)
• • ePoster
  • P266

  Migraine-cluster contiuum – Does it exist?

  • Judit Afra (Budapest, HU)
• • ePoster
  • P267

  Greater occipital nerve injection plus verapamil versus verapamil alone as first-line prophylactic treatment in episodic cluster headache: the multicentre, randomised, double-blind, placebo-controlled CHIANTI trial

  • Roemer Brandt (Leiden, NL)
• • ePoster
  • P268

  Androgen profile in cluster headache. A prospective case-controlled study

  • Anja Sofie Petersen (Glostrup, DK)
• • ePoster
  • P269

  Association between calcitonin gene-related peptide and disease states in cluster headache. A prospective and controlled study

  • Anja Sofie Petersen (Glostrup, DK)
• • ePoster
  • P270

  Role of the resting state networks in episodic cluster headache: cerebral connectivity analysis with Hd-Eeg

  • Michele Corrado (Pavia, IT)
• • ePoster
  • P271

  Beyond coincidence: clinical course and biology of coinciding cluster headache and SUNHA

  • Julia Jansen (Nijmegen, NL)
• • ePoster
  • P272

  Awareness of cluster headache among students of hail university

  • Walid Alesefir (Hail, SA)
• • ePoster
  • P273

  Switching preventive migraine treatments during the COVID-19 pandemic: a 4-year observational analysis

  • Luis Idrovo (Leeds, GB)
• • ePoster
  • P274

  Anti-CGRP in the treatment of Hereditary transthyretin amyloidosis – related migraine

  • Joana Fernandes (Porto, PT)